Fundamentals

Casi Pharmaceuticals, Inc.

CASI

Soon

Sentiment

Soon

Options

Revenue

38.05M

▲8.03M▲26.74%

12 Months Change

Assets

53.67M

▼-21.59M▼-28.69%

12 Months Change

Liabilities

51.82M

▲720.00k▲1.41%

12 Months Change

Free Cash Flow

-29.45M

▼-9.28M▼-45.99%

12 Months Change

Revenue/Cost Of Revenue

Quarterly

Net Profit/Loss

Quarterly

Assets/Liabilities

Quarterly

Cash Flows

Quarterly

Quarterly

Outstanding Shares

Quarterly

Recent Quarterly and Annual Filings

ID: 0001558370-24-004190

ID: 0001558370-23-006757